Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02311127
Other study ID # S57358
Secondary ID
Status Completed
Phase N/A
First received November 28, 2014
Last updated December 23, 2015
Start date April 2015
Est. completion date December 2015

Study information

Verified date August 2015
Source Universitaire Ziekenhuizen Leuven
Contact n/a
Is FDA regulated No
Health authority Belgium: Ethics Committee
Study type Interventional

Clinical Trial Summary

Peripherally inserted central catheters (PICCs ) are used for the administration of intravenous fluids and for blood sampling. PICCs may remain in place for weeks to months and are safeguarded from migration or accidental dislodgement by securement devices. Different types of these devices are available. StatLock® (C.R. Bard) is a stabilization device with an adhesive anchor pad. The catheter wings of the PICC must be placed over the posts then the system is closed with "gull-wings" . StatLock® has to be changed weekly. Healthcare providers have to pay attention to prevent accidental catheter dislodgement during the renewal procedure. SecurAcath® (Interrad Medical) is a new securement device to the European market. The device uses a small subcutaneous anchor to secure the PICC. One of the advantages compared to adhesive stabilization devices, is a reduction in maintenance time by simplifying dressing changes and subsequently staff time. It is described that nurses report that care is left undone due to low staffing levels. Therefore, investigation of nursing time savings with the support of technology is imperative. SecurAcath® remains in place for life of the PICC and therefore has the potential to reduce the time for dressing change as there is no need for weekly device change. The objective of this study is to measure nursing time for dressing change and explore inserting and removal issues and patient experiences.


Recruitment information / eligibility

Status Completed
Enrollment 105
Est. completion date December 2015
Est. primary completion date December 2015
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Polyurethane PICC insertion

- Dutch speaking patient, able to give informed consent

- Intravenous treatment is administered in the University Hospitals Leuven

Exclusion Criteria:

- patients with known allergy to nickel or ethylene oxide

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care


Related Conditions & MeSH terms

  • Patients With Any Condition Who Need a PICC for IV Therapy

Intervention

Device:
SecurAcath
Devices secures PICC subcutaneously and remains in place during the complete dwell time of the PICC
StatLock
Device secures PICC however, device has to be changed weekly

Locations

Country Name City State
Belgium University Hospitals Leuven Leuven

Sponsors (1)

Lead Sponsor Collaborator
Universitaire Ziekenhuizen Leuven

Country where clinical trial is conducted

Belgium, 

References & Publications (3)

Alekseyev S, Byrne M, Carpenter A, Franker C, Kidd C, Hulton L. Prolonging the life of a patient's IV: an integrative review of intravenous securement devices. Medsurg Nurs. 2012 Sep-Oct;21(5):285-92. Review. — View Citation

Egan GM, Siskin GP, Weinmann R 4th, Galloway MM. A prospective postmarket study to evaluate the safety and efficacy of a new peripherally inserted central catheter stabilization system. J Infus Nurs. 2013 May-Jun;36(3):181-8. doi: 10.1097/NAN.0b013e3182893690. — View Citation

Elen Hughes M. Reducing PICC migrations and improving patient outcomes. Br J Nurs. 2014 Jan 23-Feb 12;23(2):S12, S14-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Time needed for dressing change weekly during dressing change until catheter removal which is expected on an average after 2 weeks or up to 26 weeks No
Secondary Number of accidental removals at catheter removal which is expected on an average after 2 weeks or up to 26 weeks No
Secondary Number of catheters that migrated external catheter part will be measured weekly during dressing change until catheter removal which is expected on an average after 2 weeks or up to 26 weeks No
Secondary Catheter-related infection Labo confirmed catheter-related infection at catheter removal which is expected on an average after 2 weeks or up to 26 weeks Yes
Secondary Pain at catheter entry site related to device measured by the VAS from 0 (no pain) to 10 (worst imaginable pain) every week with the catheter dressing change until catheter removal which is expected on an average after 2 weeks or up to 26 weeks No
Secondary Ease of use of the device measured by the sumscore of the answers on 4 statements scored on a 5-item likert scale at placement (day 1) and at catheter removal which is expected on an average after 2 weeks No